Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
Oncolytic viruses induce a variety of immune targets in the infected tumours. Here, the authors show that Newcastle Disease Virus (NDV) upregulates the inducible co-stimulator (ICOS) on T cells and that intratumoral targeting of ICOS with engineered NDV in combination with CTLA-4 blockade induces sy...
Saved in:
Main Authors: | Dmitriy Zamarin, Rikke B. Holmgaard, Jacob Ricca, Tamar Plitt, Peter Palese, Padmanee Sharma, Taha Merghoub, Jedd D. Wolchok, James P. Allison |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/14d00d2c8ae14d72b432b19c11c9bf8b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies
by: Edurne Rujas, et al.
Published: (2020) -
ICO AND STO AS MODERN TOOLS FOR CROWDFUNDING STARTUPS
by: A. V. Kozhanova
Published: (2020) -
Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia
by: Yi Wang, et al.
Published: (2021) -
Initial Coin Offerings (ICOs): benefits, risks and success measures
by: Alfreda Šapkauskienė, et al.
Published: (2020) -
LEGAL APPROACHES FOR THE REGULATION OF CRYPTOCURRENCY AND ICO IN FOREIGN COUNTRIES AND THE EUROPEAN UNION
by: N. Efimova
Published: (2018)